EVLO
Evelo Biosciences Inc
$0.05
Earnings Summary
Revenue | $0Mn |
Net Profits | $-12.36Mn |
Net Profit Margins | -Inf% |
Highlights
Evelo Biosciences Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Evelo Biosciences Inc has generated NaN% jump in its revenue since last 3-months.
Evelo Biosciences Inc’s net profit jumped 59.55% since last year same period to $-12.36Mn in the Q3 2023. On a quarterly growth basis, Evelo Biosciences Inc has generated 41.41% jump in its net profits since last 3-months.
Evelo Biosciences Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Evelo Biosciences Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Evelo Biosciences Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.97 |
EPS Estimate Current Year | -0.97 |
Highlights
Evelo Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.97 - a 70.61% jump from last quarter’s estimates.
Evelo Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.97.
Key Ratios
Key ratios of the Evelo Biosciences Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -0.71 |
Highlights
Evelo Biosciences Inc’s earning per share (EPS) fell -154% since last year same period to -0.71 in the Q3 2023. This indicates that the Evelo Biosciences Inc has generated -154% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-09 | -0.97 | -0.71 | 26.68% |
2023-05-15 | -0.16 | -0.23 | -43.75% |
2023-08-14 | -3.3 | -3.78 | -14.55% |
₹0 US Stocks a/c Opening Fee